Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started
Sign up to stay up to date with the stocks you care about
Follow Natera, Inc.

Get SEC filing alerts via email and in your feed for Natera, Inc.

NTRA

Natera, Inc.

About Natera, Inc.

Natera, Inc. is a diagnostics company specializing in cell-free DNA technology for non-invasive genetic testing across women’s health, oncology, and organ health. Its core products include prenatal tests, carrier screening, cancer residual disease detection, and transplant rejection monitoring. The company leverages proprietary molecular assays and cloud-based platforms to deliver high-accuracy, scalable solutions globally, serving healthcare providers, laboratories, and patients.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Natera, Inc.

1
1
2
1
3
1